| Literature DB >> 27043593 |
Cécile Marie1, Sophie Cabut2, Françoise Vendittelli3,4,5, Marie-Pierre Sauvant-Rochat6,7.
Abstract
Cosmetic products contain various chemical substances that may be potential carcinogen and endocrine disruptors. Women's changes in cosmetics use during pregnancy and their risk perception of these products have not been extensively investigated. The main objective of this study was to describe the proportion of pregnant women changing cosmetics use and the proportion of non-pregnant women intending to do so if they became pregnant. The secondary objectives were to compare, among the pregnant women, the proportions of those using cosmetics before and during pregnancy, and to describe among pregnant and non-pregnant women, the risk perception of these products. A cross-sectional study was carried out in a gynaecology clinic and four community pharmacies. One hundred and twenty-eight women (60 non-pregnant and 68 pregnant women) replied to a self-administered questionnaire. Cosmetics use was identified for 28 products. The results showed that few women intended to change or had changed cosmetics use during pregnancy. Nail polish was used by fewer pregnant women compared to the period before pregnancy (p < 0.05). Fifty-five percent of the women considered cosmetics use as a risk during pregnancy and 65% would have appreciated advice about these products. Our findings indicate that all perinatal health professionals should be ready to advise women about the benefits and risks of using cosmetics during pregnancy.Entities:
Keywords: cosmetics; endocrine disruptors; health education; personal care products; pregnancy; risk perception
Mesh:
Substances:
Year: 2016 PMID: 27043593 PMCID: PMC4847045 DOI: 10.3390/ijerph13040383
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Socio-demographic and obstetric characteristics of women (n = 128).
| Personal Information | Total | NPW Group | PW Group | |
|---|---|---|---|---|
| Age | - | |||
| in years | 30.5 ± 5.8 | 30.7 ± 7.4 | 30.2 ± 3.9 | 0.67 |
| Town of residence | - | |||
| ≤5000 inhabitants | 82 (66.1) | 30 (52.6) | 52 (77.6) | <0.01 |
| >5000 inhabitants | 42 (33.9) | 27 (47.4) | 15 (22.4) | - |
| Educational level | - | |||
| Junior school | 8 (6.3) | 5 (8.5) | 3 (4.4) | 0.70 |
| High school | 24 (18.9) | 11 (18.6) | 13 (19.1) | - |
| University level | 95 (74.8) | 43 (72.9) | 52 (76.5) | - |
| - | ||||
| Executive and intellectual professions | 28 (21.9) | 13 (21.7) | 15 (22.1) | 1.00 |
| Intermediate professions c | 46 (35.9) | 21 (35.0) | 25 (36.8) | - |
| Employees | 40 (31.3) | 19 (31.7) | 21 (30.9) | - |
| Others d | 4 (3.1) | 2 (3.3) | 2 (2.9) | - |
| No occupation | 10 (7.8) | 5 (8.3) | 5 (7.4) | - |
| - | ||||
| ≥1 | 65 (51.2) | 32 (53.3) | 33 (49.3) | 0.78 |
| - | ||||
| Outside of pregnancy | 19 (14.8) | 13 (21.7) | 6 (8.8) | 0.05 |
a m ± SD: mean ± standard deviation; b Socioprofessional categories are presented according to the French nomenclature (Institut national de la statistique et des études économiques); c Intermediate professions comprises education (e.g., teachers), health (e.g., nurses) and public services; d Others: Artisans, retailers and company head (n = 1), manual workers (n = 2), student (n = 1); e Chronic treatments for NPW group: Allopathic treatment (ebastine (n = 2), rosuvastatin (n = 1), venlafaxine (n = 1), escitalopram (n = 1), proton-pump inhibitor (n = 1), interferon beta-1a (n = 1), chlormadinone and topiramate (n = 1), modafinil and sodium oxybate (n = 1), zinc gluconate, benzoyl peroxid and adapalene (n = 1), rivaroxaban, thiamazole and levothyroxine (n = 1)), homeopathic treatment (n = 2); Chronic treatments for PW group: zolmitriptan (n = 1), duloxetine and valproic acid (n = 1), ebastine and budesonide (n = 1), levothyroxine (n = 1), levothyroxine and cetirizine (n = 1), dietary supplement (n = 1). NPW: non-pregnant women; PW: pregnant women.
Proportion of women reporting regular use of personal care products outside of pregnancy (n = 128).
| Personal Care Product | Total | NPW Group | PW Group | |
|---|---|---|---|---|
| Shower gel | 120 (93.7) | 54 (90.0) | 66 (97.1) | 0.15 |
| Solid soap | 45 (32.5) | 24 (40.0) | 21 (30.9) | 0.37 |
| Dermatological soap a | 22 (17.5) | 15 (25.9) | 7 (10.3) | 0.03 |
| Intimate hygiene product a | 58 (46.0) | 27 (45.8) | 31 (46.3) | 1 |
| Body scrub | 51 (39.8) | 25 (41.7) | 26 (38.2) | 0.83 |
| Body lotion | 92 (71.9) | 46 (76.7) | 47 (69.1) | 0.45 |
| Deodorant b | 117 (92.1) | 55 (91.7) | 62 (92.5) | 1 |
| Perfume b | 116 (91.3) | 56 (93.3) | 61 (91.0) | 0.75 |
| Bronzers | 1 (0.8) | 0 | 1 (1.5) | |
| Facial cleanser a | 77 (60.6) | 39 (66.1) | 38 (55.9) | 0.32 |
| Day face cream | 105 (82.0) | 52 (86.7) | 53 (77.9) | 0.25 |
| Night face cream | 24 (18.7) | 12 (20.0) | 12 (17.7) | 0.91 |
| Facial scrub | 56 (43.7) | 30 (50.0) | 26 (38.2) | 0.25 |
| Facial mask | 45 (35.2) | 21 (35.0) | 24 (35.3) | 1 |
| Shampoo | 126 (98.4) | 59 (98.3) | 67 (98.5) | 1 |
| Hair mask | 55 (43.0) | 22 (36.7) | 33 (48.5) | 0.24 |
| Hair dye a | 43 (34.1) | 18 (30.5) | 25 (37.3) | 0.55 |
a 2 missing responses; b 1 missing response. NPW: non-pregnant women; PW: pregnant women.
Proportion of women reporting regular use of make-up products outside of pregnancy (n = 128).
| Make-Up Product | Total | NPW Group | PW Group | |
|---|---|---|---|---|
| 74 (57.8) | 32 (53.3) | 42 (61.8) | 0.43 | |
| 36 (28.1) | 19 (31.7) | 17 (25.0) | 0.52 | |
| 110 (85.9) | 52 (86.7) | 58 (85.3) | 1 | |
| 43 (33.6) | 23 (38.3) | 20 (29.4) | 0.35 | |
| 93 (72.7) | 41 (68.3) | 52 (76.5) | 0.41 | |
| 88 (68.7) | 41 (68.3) | 47 (69.1) | 1 | |
| 58 (45.3) | 25 (41.7) | 33 (48.5) | 0.55 | |
| 12 (9.4) | 6 (10.2) | 7 (10.5) | 1 | |
| 104 (81.3) | 51 (85.0) | 53 (77.9) | 0.38 | |
| 96 (75.0) | 41 (68.3) | 55 (80.9) | 0.15 | |
| 92 (73.6) | 41 (68.3) | 51 (78.5) | 0.28 |
1 missing response; 3 missing responses; NPW: non-pregnant women; PW: pregnant women.
Figure 1Criteria of choice of products outside of pregnancy. (A) PCPs for general hygiene; (B) PCPs for hair and face; (C) make-up products. Abbreviations: NPW, non-pregnant women; PCP: personal care product; PW: pregnant women.
Figure 2Proportion of women intending to change (NPW) or having changed (PW) the use of cosmetics during pregnancy. (A) PCPs for general hygiene; (B) PCPs for hair and face; (C) make-up products. * p = 0.04. Abbreviations: Eye make-up, eyeliner, eye shadow, eye pencil and mascara; Face make-up, foundation make-up and blush; Lip make-up, lip pencil and lipstick; NPW: non-pregnant women; PW: pregnant women.
Figure 3Proportion of pregnant women (PW, n = 68) using cosmetics outside and during pregnancy. * p < 0.05; ** p ≤ 0.1; Abbreviations: PW: pregnant women.
Figure 4Criteria of choice of cosmetics during pregnancy. The percentages were calculated only in the subgroups of NPW who declared an intention to change cosmetics use during pregnancy. Shower gel (n = 7), solid soap and dermatological soap (n = 4), intimate hygiene product (n = 8), body lotion (n = 13), perfume (n = 7), deodorant (n = 12), face PCP (n = 9), shampoo and hair mask (n = 6), hair dye (n = 11), nail polish (n = 12) and nail polish remover (n = 13). The percentages were calculated only in the subgroup of PW having changed cosmetics use during pregnancy. Shower gel (n = 10), solid soap and dermatological soap (n = 3), intimate hygiene product (n = 7), body lotion (n = 22), perfume (n = 10), deodorant (n = 5), face PCP (n = 9), shampoo and hair mask (n = 3), hair dye (n = 10), nail polish (n = 9) and nail polish remover (n = 10). * Face PCP corresponds to facial cleanser, day face cream, night face cream, facial scrub, make-up remover and foundation. Abbreviations: NPW: non-pregnant women, PW: pregnant women.
Figure 5Risk perception related to cosmetic products. (A) Outside of pregnancy; (B) During pregnancy. All p-values >0.05. Abbreviations: NPW: non-pregnant women; PW: pregnant women.
Figure 6Advice received from health professionals about cosmetics. Outside of pregnancy: proportion of women having received advice (NPW and PW). During pregnancy: proportion of women wishing to receive advice (NPW) or having received advice (PW). All p-values > 0.05. Abbreviations: NPW: non-pregnant women; PCPs: personal care products; PW: pregnant women.